Association for the Promotion of Quality Control in Medical Biology
| EQA 2024 - Serum Indices: Hemolysis / Jaundice / Lipemia (HIL) |
|---|
|
Expert Biologists - Scheme Coordinators:
Régine CARTIER, Marie LOPEZ, Matthieu PECQUET and Bernard POGGI EQA performed since 2018
Number of participating laboratories in 2023: 661 |
| Scheme organized by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Scheme overview
Hemolysis, jaundice and lactescence of biological samples are the source of analytical interference . Most analyzers currently offer a possibility of quantifying serum indices allowing automated management of this interference. However, there is no standardization of these measures.
The aim of the proposed scheme is to help the laboratory to better control of the quality of index measurements by enabling it to assess its accuracy.
This scheme is suitable for all analyzers performing a measurement of serum indices (chemistry analyzers, hemostasis, serology, etc.).
INFORMATION: Two posters were presented during the 1st Francophone Days of Medical Biology, in September 2017, in Bordeaux:
2 – Assessment frequency
Number of investigations per year : 4
Number of control samples per investigation: 2
Number of samples per year: 8
3 – List of analytes assessed
4 – Description of the control samples
Lyophilized human control samples (to be resuspended in 1 mL of distilled water).
| | Confidentiality Policy | General Terms of Sale | | Last updated : 04/09/2023 | Copyright © 2011-2023 ProBioQual All rights reserved. |